This analysis uses 2023 Medicare claims for traditional Medicare, Medicare Advantage encounter data, and Part D prescription drug event data to estimate the total number of Medicare beneficiaries with obesity or overweight, the number of Part D enrollees who met the Bridge eligibility criteria in 2023, and those who met the Bridge clinical criteria but who also had diagnoses recorded in claims or encounter data that would qualify for Part D coverage of GLP-1s (type 2 diabetes, OSA, or MASH) or who had a GLP-1 Part D-covered prescription during the year, either of which would make them ineligible for Bridge (see Methods)
The rate of new onset of heart failure (HR 0.92
doi:10.1016/j.metop.2022.10022 Jastreboff AM, Aronne LJ, Ahmad NN, et al
Changing behavior takes time and does not happen overnight, which is why choosing the right care platform like Everlywell is ideal
Clinics like Ava Health offer professional testing to ensure your results are trustworthy
Silk fibroin nanoparticle as a novel drug delivery system
